17, 189-200 (2000).
5. Bobe, R. et al., Platelets, 16, 133-150 (2005).
6. Martin, V. et al., J. Biol. Chem., 277, 24442-24452
(2002).
7. Chaabane, C. et al., Biochem. Biophys. Res.
Comm., 345
Development, Production, and Safety of
Biosynthetic Human Insulin, Diabetes Care 16
(Suppl 3), 133-142 (1993).
3. Johnson, IS. Authenticity and purity of human
insulin (recombinant DNA). Diabetes
Development, Production, and Safety of
Biosynthetic Human Insulin, Diabetes Care 16
(Suppl 3), 133-142 (1993).
3. Johnson, IS. Authenticity and purity of human
insulin (recombinant DNA). Diabetes
G., et al., Am. J. Pathol., 133, 369 (1988).
5. Altmannsberger, M., et al., Lab. Invest., 46, 520,
(1982).
6. Osborn, M., and Weber, K., Cell, 31, 303 (1982).
7. Osborn, M., and Weber
analysis of glycoprotein
oligosaccharides by mass spectrometry. Arch.
Biochem. Biophys., 224, 127-133 (1983).
7. Boyer, P.D., The Enzymes, Academic Press (New
York), 3rd ed., Vol. III, p. 277-321 (1971).
Endotoxemia-Associated
Inflammation Along the Gut-Liver Axis". The Ohio
State University, Ph.D. dissertation, p. 133
(2020).
22. Correia, Mario S.P., "Development of chemical
biology tools for metabolomics analysis
64, 2323,
1992.
29. Xu, Q. et al., Am. J. Hosp. Pharm., 51, 3058, 1994.
30. Dordunoo, S.K., and Burt, H.M., Int. J. Pharmaceu.,
133, 191, 1996.
Taxol is a registered trademark of Bristol-Myers
64, 2323,
1992.
29. Xu, Q. et al., Am. J. Hosp. Pharm., 51, 3058, 1994.
30. Dordunoo, S.K., and Burt, H.M., Int. J. Pharmaceu.,
133, 191, 1996.
Taxol is a registered trademark of Bristol-Myers